2-methoxyestradiol has been researched along with Dysmyelopoietic Syndromes in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (75.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, BA; Ding, JH; Gao, C; Hu, LL; Lu, HX; Shao, ZY; Xia, GH | 1 |
Chen, B; Ding, J; Gao, C; Gao, F; Lu, H; Shao, Z; Wang, X; Xia, G | 1 |
Chen, BA; Hartmut, D; Konstanze, D; Lu, HX; Shao, ZY; Xia, GH | 1 |
Chen, BA; Ding, JH; Gao, C; Lu, HX; Shao, ZY; Xia, GH | 1 |
4 other study(ies) available for 2-methoxyestradiol and Dysmyelopoietic Syndromes
Article | Year |
---|---|
[Regulation of 2-methoxyestradiol-induced cell apoptosis by mcl-1 and bax genes in myelodysplastic syndrome].
Topics: 2-Methoxyestradiol; Apoptosis; bcl-2-Associated X Protein; Caspase 3; Cell Line, Tumor; Estradiol; Humans; Myelodysplastic Syndromes; Myeloid Cell Leukemia Sequence 1 Protein; Proto-Oncogene Proteins c-bcl-2 | 2009 |
Effect of magnetic Fe3O4 nanoparticles with 2-methoxyestradiol on the cell-cycle progression and apoptosis of myelodysplastic syndrome cells.
Topics: 2-Methoxyestradiol; Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Cycle Proteins; Cell Line; Cell Proliferation; Drug Carriers; Drug Delivery Systems; Estradiol; Humans; Magnetite Nanoparticles; Myelodysplastic Syndromes; Nanomedicine; Particle Size | 2011 |
Mechanism of 2-methoxyestradiol-induced apoptosis in myelodysplastic syndrome MUTZ-1 cell line.
Topics: 2-Methoxyestradiol; Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Estradiol; Humans; L-Lactate Dehydrogenase; Myelodysplastic Syndromes | 2007 |
[Alterations of telomerase activity and apoptosis induced by 2-methoxyestradiol in human myelodysplastic syndrome cell line MUTZ-1].
Topics: 2-Methoxyestradiol; Apoptosis; Cell Cycle; Cell Line; Estradiol; Humans; Myelodysplastic Syndromes; Telomerase | 2007 |